Predictive and prognostic biomarkers with therapeutic targets in advanced colorectal cancer.

Katsuhiko Nosho, Takako Kawasaki, Janina A. Longtine, Charles S. Fuchs, Mutsuko Ohnishi, Yuko Suemoto, Gregory J. Kirkner, Dimity Zepf, Liying Yan, Shuji Ogino, PIK3CA Mutation in Colorectal Cancer: Relationship with Genetic and Epigenetic Alterations Neoplasia. ,vol. 10, pp. 534- 541 ,(2008) , 10.1593/NEO.08336

Ben Markman, Francisco Javier Ramos, Jaume Capdevila, Josep Tabernero, EGFR and KRAS in colorectal cancer. Advances in Clinical Chemistry. ,vol. 51, pp. 71- 119 ,(2010) , 10.1016/S0065-2423(10)51004-7

Sarah Edkins, Sarah O'Meara, Adrian Parker, Claire Stevens, Marcelo Reis, Siân Jones, Chris Greenman, Helen Davies, Gillian Dalgliesh, Simon Forbes, Chris Hunter, Raffaella Smith, Philip Stephens, Peter Goldstraw, Andrew Nicholson, Tsun Leung Chan, Victor E Velculescu, Siu Tsan Yuen, Suet Yi Leung, Michael R Stratton, P Andrew Futreal, Recurrent KRAS Codon 146 Mutations in Human Colorectal Cancer Cancer Biology & Therapy. ,vol. 5, pp. 928- 932 ,(2006) , 10.4161/CBT.5.8.3251

G. I Meling, P Laurent-Puig, B. J Iacopetta, R Glaesener, O. P. F Clausen, F Al-Mulla, W Giaretti, V. J Bubb, A. F. P. M de Goeij, G Gaudernack, T Ohkusa, P Quirke, A Rapallo, N Hawkins, R Rosell, T. O Rognum, S. N Andersen, R Smith, J Costa, R Ward, I Hoffmann, T Fujimori, D Cunningham, D Morton, C. T Croke, J Oates, X. F Sun, S Bell, P. A Clarke, S. T Wang, J Breivik, O Muller, A. R Norman, J. W Arends, M Pauly, D Dillon, H. J. N Andreyev, S. D Finkelstein, A. J Senagore, C. N Hall, K Wilkinson, N Lees, N. R Cruickshank, H. S Goh, D Snary, E Jullian, C Valavanis, L Losi, A Russo, H. M Rabes, J Piris, S Wadler, Y Ono, T Azuma, A Font, C Zietz, M Beranek, J. C Fox, S. A Halter, R Benamouzig, B. R Dix, H Zhang, C Faber, K Omura, V. E Pricolo, C Troungos, K Krtolica, J Benhattar, J. W. C Ho, N. Urosevic, T Lovig, D. P O'Donoghue, J. S Thebo, P De Angelis, J. Q Lee, J Young, Bazan, P Jandik, S Olschwang, S. T Yuen, T Walsh, S Malik, M Tanaka, Kirsten ras mutations in patients with colorectal cancer : the ‘RASCAL II’ study Faculty of Health; Institute of Health and Biomedical Innovation. ,vol. 85, pp. 692- 696 ,(2001)

Peter Carmeliet, Rakesh K. Jain, Angiogenesis in cancer and other diseases Nature. ,vol. 407, pp. 249- 257 ,(2000) , 10.1038/35025220

Zenya Naito, Osamu Komine, Masanori Watanabe, Tetsuo Shibuya, Masanori Yoshino, Akira Tokunaga, Toshiyuki Ishiwata, Keratinocyte growth factor receptor expression in normal colorectal epithelial cells and differentiated type of colorectal cancer. Oncology Reports. ,vol. 13, pp. 247- 252 ,(2005) , 10.3892/OR.13.2.247

Gabriel Capellà, Lourdes Farré, Isolda Casanova, Adela Mazo, Sílvia Guerrero, Ramon Mangues, K-ras codon 12 mutation induces higher level of resistance to apoptosis and predisposition to anchorage-independent growth than codon 13 mutation or proto-oncogene overexpression. Cancer Research. ,vol. 60, pp. 6750- 6756 ,(2000)

A K Koutras, A G Antonacopoulou, A G Eleftheraki, F-I Dimitrakopoulos, A Koumarianou, I Varthalitis, F Fostira, J Sgouros, E Briasoulis, E Bournakis, D Bafaloukos, I Bompolaki, E Galani, K T Kalogeras, D Pectasides, G Fountzilas, H P Kalofonos, Vascular endothelial growth factor polymorphisms and clinical outcome in colorectal cancer patients treated with irinotecan-based chemotherapy and bevacizumab Pharmacogenomics Journal. ,vol. 12, pp. 468- 475 ,(2012) , 10.1038/TPJ.2011.37

Aurélien de Reyniès, Valérie Boige, Gérard Milano, Jean Faivre, Pierre Laurent-Puig, KRAS mutation signature in colorectal tumors significantly overlaps with the cetuximab response signature. Journal of Clinical Oncology. ,vol. 26, pp. 2228- 2230 ,(2008) , 10.1200/JCO.2007.15.9186

Kimmie Ng, Andrew X. Zhu, Targeting the epidermal growth factor receptor in metastatic colorectal cancer. Critical Reviews in Oncology Hematology. ,vol. 65, pp. 8- 20 ,(2008) , 10.1016/J.CRITREVONC.2007.09.006